miR-335-5p suppresses gastric cancer progression by targeting MAPK10
Yi Gao,Yanfeng Wang,Xiaofei Wang,Changan Zhao,Fenghui Wang,Juan Du,Huahua Zhang,Haiyan Shi,Yun Feng,Dan Li,Jing Yan,Yan Yao,Weihong Hu,Ruxin Ding,Mengjie Zhang,Lumin Wang,Chen Huang,Jing Zhang
DOI: https://doi.org/10.1186/s12935-020-01684-z
IF: 6.429
2021-01-22
Cancer Cell International
Abstract:Abstract Background Recent studies have established the roles of microRNAs (miRNAs) in cancer progression. The aberrant expression of miR-335-5p has been reported in many cancers, including gastric cancer (GC). In this study, the precise roles of miR-335-5p in GC as well as the molecular mechanisms underlying its effects, including the role of its target MAPK10, were evaluated. Methods Quantitative real-time PCR was used to evaluate miR-335-5p levels in GC cell lines and tissues. MTT and colony formation assays were used to detect cell proliferation, and Transwell and wound-healing assays were used to evaluate the invasion and migration of GC cells. The correlation between levels of miR-335-5p and the cell cycle-related target gene mitogen-activated protein kinase 10 (MAPK10) in GC was analyzed. In addition, the candidate target was evaluated by a luciferase reporter assay, qRT-PCR, and western blotting. Results The levels of miR-335-5p were downregulated in GC tissues and cell lines. Furthermore, miR-335-5p inhibited the proliferation and migration of GC cells and induced apoptosis. Additionally, miR-335-5p arrested the cell cycle at the G1/S phase in GC cells in vitro. Levels of miR-335-5p and the cell cycle-related target gene MAPK10 in GC were correlated, and MAPK10 was directly targeted by miR-335-5p. Conclusions These data suggest that miR-335-5p is a tumor suppressor and acts via MAPK10 to inhibit GC progression.
oncology